abrdn Life Sciences Investors
Symbol: HQL (NYSE)
16.80
▲ (2.47%) 0.405
Company Description:
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
Key Stats
- Today's Open: $16.79
- Today's High: $16.94
- Today's Low: $16.396
- Today's Volume: 750.47K
- Yesterday Close: $16.39
- Yesterday High: $16.44
- Yesterday Low: $16.23
- Yesterday Volume: 104.06K
- Last Min Volume: 99
- Last Min High: $16.795
- Last Min Low: $16.795
- Last Min VWAP: $16.795
Company Profile
- Name: abrdn Life Sciences Investors
- Website: https://www.abrdnhql.com
- Listed Date: 1992-05-01
- Location: ,
- Market Status: Active
- CIK Number: 0000884121
- SIC Code:
- SIC description:
- Market Cap: $485.63M
- Round Lot: 100
- Outstanding Shares: 28.87M
- Asset Type: FUND
RECENT FILINGS FOR HQL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-26 | SCHEDULE 13D/A | View |
| 2025-09-23 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-15 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-03 | SCHEDULE 13D/A | View |
| 2025-09-02 | 4 | View |
| 2025-08-29 | N-PX | View |
| 2025-08-28 | NPORT-P | View |
| 2025-08-27 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-07-29 | 40-17G | View |
| 2025-07-22 | 3 | View |
| 2025-06-09 | N-CSRS | View |
| 2025-05-29 | NPORT-P | View |
| 2025-05-22 | 4 | View |
| 2025-05-19 | 4 | View |
| 2025-05-15 | 4 | View |
| 2025-05-12 | 4 | View |
Latest News on HQL